Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 531 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)

NCT03606590

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University Hospital Fakultni Nemocnice Olomouc, Oncology Clinic Olomouc, Czechia
  • CHU de Nantes Nantes, France
  • University Medical Center - University of Freiburg Freiburg im Breisgau, Germany
  • Ulm University Hospital Ulm, Germany
View Trial Details
Completed

GEN2 Directed Cancer Immunotherapy Trial

NCT04313868

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Makati Medical Center Makati City, Philippines
  • The Medical City Pasig, Philippines
  • National Kidney and Transplant Institute Quezon City, Philippines
  • St. Luke's Medical Center Quezon City, Philippines
View Trial Details
Completed

Study of BGB-A317 in Participants With Previously Treated Unresectable HCC

NCT03419897

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Military Hospital of China Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 54 locations
View Trial Details
Completed

A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer

NCT03941873

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North) Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Completed

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

NCT02511522

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Dr. H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada
  • Royal Victoria Regional Health Centre Barrie, Ontario, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
View Trial Details

Related conditions